Tag: generic drug surveillance
The FDA monitors generic drug safety after approval through real-time reporting, manufacturing data, and patient feedback. Learn how adverse events are tracked, what gaps exist, and what’s changing in 2025 to improve detection of quality and effectiveness issues.
Archives
Recent-posts
Deficiency Letters in Generic Drug Applications: Common FDA Findings and How to Avoid Them
Jan, 16 2026

Medications